Vio3apc3
Payments companies reported to CMS as associated with Vio3apc3. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Vio3apc3, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Vio3apc3
These are the largest totals companies reported as associated with Vio3apc3. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Erik Rahimi | Lakeway, TX | Gastroenterology (Internal Medicine) | $243.25 |
| Jeff Angelo Taclob | Lubbock, TX | Internal Medicine | $86.19 |
| Richa Shukla | Houston, TX | Gastroenterology (Internal Medicine) | $86.19 |
| Harish Kumar Gopalakrishna Pillai | Galveston, TX | Gastroenterology (Internal Medicine) | $86.19 |
| Jonathan Selzman | San Antonio, TX | Hospitalist | $86.19 |
| Kevin Pak | Fort Sam Houston, TX | Transplant Hepatology | $86.19 |
| Jordan Malone | Galveston, TX | Gastroenterology (Internal Medicine) | $86.19 |
| Anish Patel | Fort Sam Houston, TX | Gastroenterology (Internal Medicine) | $86.19 |
| Lauren Lyssy | Fort Worth, TX | Internal Medicine | $86.19 |
| Brian Lee | San Antonio, TX | Hospitalist | $86.19 |
Prescribed Vio3apc3?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.